Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poonam Giri

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 12, 2019
Lack of inhibition of CYP2C8 by saroglitazar magnesium: In vivo assessment using montelukast, rosiglitazone, pioglitazone, repaglinide and paclitaxel as victim drugs in Wistar ratsPoonam Giri, Prashant Delvadia, Meera K Ladani, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Discovery of a Potent and Orally Efficacious TGR5 Receptor AgonistSameer Agarwal, Amit Patil, Umesh Aware, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2024
Discovery of aminopiperidine based potent & novel topoisomerase inhibitor with broad spectrum anti-bacterial activityJigar Desai, Bhaumin Patel, Nandini Panchal, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2019
Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones based novel, potent and PI3Kδ selective inhibitorsRajesh Bahekar, Bhushan Dave, Shubhangi Soman, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of <i>N</i>-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome InhibitorsSameer Agarwal, Santosh Sasane, Hardik A Shah, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2022
Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitorJigar Desai, Bhaumin Patel, Archana Gite, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2021
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B<sup>0</sup>AT1 (SLC6A19)Jigar Desai, Bhaumin Patel, Brijesh Darji, et al.
Chemico-Biological Interactions|May 11, 2026
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar ratsPraveen Kumar Jain, Laxit K Bhatt, Ashvin K Patel, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Pharmacology Research & Perspectives|August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancerKrishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 12, 2019
Lack of inhibition of CYP2C8 by saroglitazar magnesium: In vivo assessment using montelukast, rosiglitazone, pioglitazone, repaglinide and paclitaxel as victim drugs in Wistar ratsPoonam Giri, Prashant Delvadia, Meera K Ladani, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Discovery of a Potent and Orally Efficacious TGR5 Receptor AgonistSameer Agarwal, Amit Patil, Umesh Aware, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2024
Discovery of aminopiperidine based potent & novel topoisomerase inhibitor with broad spectrum anti-bacterial activityJigar Desai, Bhaumin Patel, Nandini Panchal, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2019
Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones based novel, potent and PI3Kδ selective inhibitorsRajesh Bahekar, Bhushan Dave, Shubhangi Soman, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of <i>N</i>-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome InhibitorsSameer Agarwal, Santosh Sasane, Hardik A Shah, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2022
Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitorJigar Desai, Bhaumin Patel, Archana Gite, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2021
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B<sup>0</sup>AT1 (SLC6A19)Jigar Desai, Bhaumin Patel, Brijesh Darji, et al.
Chemico-Biological Interactions|May 11, 2026
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar ratsPraveen Kumar Jain, Laxit K Bhatt, Ashvin K Patel, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Pharmacology Research & Perspectives|August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancerKrishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
Pageof 3